News | News By Subject | News by Disease News By Date | Search News
Get Our FREE
Industry eNewsletter
email:    
   

Medivation, Inc. (MDVN) Announces Participation at Upcoming Investor Conferences



5/7/2013 10:17:45 AM

SAN FRANCISCO, CA--(Marketwired - May 06, 2013) - Medivation, Inc. (NASDAQ: MDVN) today announced that it will present at the following conferences:

  • David Hung, M.D., president and chief executive officer, will present at the UBS Global Healthcare Conference on May 20 at 1pm ET at the Grand Hyatt in New York, NY.
  • David Hung, M.D., president and chief executive officer, will present at the 38th Annual dbAccess Health Care Conference on May 29 at 4:50pm ET at the Westin Boston Waterfront in Boston, MA.
  • Patrick Machado, chief business and financial officer, will present at the Jefferies 2013 Global Healthcare Conference on June 3 at 11am ET at the Grand Hyatt in New York, NY.
  • David Hung, M.D., president and chief executive officer, will present at the Goldman Sachs 34th Annual Global Healthcare Conference, on June 11 at 4pm PT at the Terranea Resort in Rancho Palos Verdes, CA.

Individuals may access the live audio webcast by visiting: http://investors.medivation.com/events.cfm. A replay of the webcast will be available on the Company's website for 30 days following the live event.

About Medivation
Medivation, Inc. is a biopharmaceutical company focused on the rapid development of novel therapies to treat serious diseases for which there are limited treatment options. Medivation aims to transform the treatment of these diseases and offer hope to critically ill patients and their families. For more information, please visit us at www.medivation.com.


Contacts:
Patrick Machado
Chief Business & Financial Officer
(415) 829-4101

Anne Bowdidge
Sr. Director, Investor Relations
(650) 218-6900


Read at BioSpace.com

Related News

comments powered by Disqus
   

ADD TO DEL.ICIO.US    ADD TO DIGG    ADD TO FURL    ADD TO STUMBLEUPON    ADD TO TECHNORATI FAVORITES